Protecting participant data is of the utmost importance in clinical research. This article breaks down risk-based monitoring, as well as other data protection terms falling underneath it.
In this Q&A, Shannon Roznoski from Advarra-Forte and Michael Buckley from Memorial Sloan Kettering Cancer Center answer attendee questions from their webinar, How Sites and Sponsors are Collaborating to Move eSource Forward
By inverting the focus from per protocol solutions to holistic site-wide solutions that utilize industry standards, we can revolutionize the use of eSource in clinical trials.
At this year’s CCAF conference, we will host a pre-conference workshop, “Research Administration Technology Workshop”, allowing us to work collaboratively with the clinical research community.
Many sites understand the benefits of moving from paper regulatory binders to an electronic system. But it’s also important to ensure your organization is implementing a system that will fit your regulatory workflows and set you up for long-term success.
Forte’s director of product management attended the SCDM Annual Conference earlier this month, and took the time to reflect on the growth of the clinical data management domain.
When Wayne State University (WSU) wanted to take on more IND and IDE trials, they chose Forte EDC and Forte’s Validation Service to help streamline the process.
Leveraging technology is essential to successfully streamlining the start-up and conduct of trials. From clinical trial management systems to electronic regulatory management systems, clinical research technology has been instrumental in making improvements in the entire protocol lifecycle.